You are currently viewing Novo Nordisk limits Wegovy doses for new patients as demand outpaces supply – CNN

Novo Nordisk limits Wegovy doses for new patients as demand outpaces supply – CNN

Novo Nordisk, maker of the weight-loss drug Wegovy, said it would limit supply of starter doses as demand outpaces the companys manufacturing capacity.
The supply interruptions arent expected to aff… [read more]

Leave a Reply